Seth Wilson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seth Wilson has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Ryan C. Rauck
Department of Orthopaedics, The Ohio State University College of Medicine, Columbus, OH, USA
7 shared publications Gregory L. Cvetanovich
Department of Orthopaedics, The Ohio State University College of Medicine, Columbus, OH, USA
6 shared publicationsJulie Y. Bishop
Department of Orthopaedics, The Ohio State University College of Medicine, Columbus, OH, USA
6 shared publications- Erryk S. Katayama
Department of Orthopaedics, The Ohio State University College of Medicine, Columbus, OH, USA
5 shared publications - Louis W. Barry
Department of Orthopaedics, The Ohio State University College of Medicine, Columbus, OH, USA
5 shared publications Akshar V. Patel
Department of Orthopaedics, The Ohio State University College of Medicine, Columbus, OH, USA
4 shared publications
Latest Publications
- Open Access
- 23 December 2025
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (5) , 2329-2336
Operative Difficulties and Post-Surgical Outcomes in “Super Morbidly Obese” (Class 4+) Patients
Study Design: Retrospective Cohort Study. Objective: Obesity rates have risen over recent decades, with many affected individuals experiencing degenerative spine conditions. A parallel increase in spine surgeries has raised questions about how to best optimize care in obese patients. Those with extremely high BMI (>50), classified as “Super Morbidly Obese (SMO)”, may face higher risks of poor surgical outcomes. To better understand the challenges in treating this population, we compared complications, and operative characteristics between morbidly obese (MO), and SMO. Methods: A single-institution retrospective review was conducted on patients with a BMI over 40 who underwent a neurosurgical procedure from 2017 to 2023. Inclusion criteria were (1) patient age >17 years, (2) BMI >40, and (3) surgical interventions performed by a member of the department of neurological surgery. Demographic, clinical, surgical, and post-operative follow-up were analyzed. Results: Patients were split into SMO (BMI 50+) and MO (BMI 40-50) groups. SMO received more intra-operative imaging radiation ( P = 0.0169), experienced longer hospital stays ( P < 0.0005) and experienced more post-operative complications than MO patients ( P = 0.008). SMO patients experienced more complications when discharged home than their MO counterparts ( P = 0.0002, RR = 12.2 [2.7-53.4]). Conclusion: Risk in SMO spine surgery can be reduced through weight loss, modified surgical approaches, and better discharge planning. Regardless of comorbidities, SMO patients discharged home face higher complication rates than MO patients and may benefit from early discussions about skilled nursing placement. Larger studies are needed to better assess surgical management and outcomes in this population.
- 23 December 2025
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (5) , 2329-2336
Open AccessOperative Difficulties and Post-Surgical Outcomes in “Super Morbidly Obese” (Class 4+) Patients
Study Design: Retrospective Cohort Study. Objective: Obesity rates have risen over recent decades, with many affected individuals experiencing degenerative spine conditions. A parallel increase in spine surgeries has raised questions about how to best optimize care in obese patients. Those with extremely high BMI (>50), classified as “Super Morbidly Obese (SMO)”, may face higher risks of poor surgical outcomes. To better understand the challenges in treating this population, we compared complications, and operative characteristics between morbidly obese (MO), and SMO. Methods: A single-institution retrospective review was conducted on patients with a BMI over 40 who underwent a neurosurgical procedure from 2017 to 2023. Inclusion criteria were (1) patient age >17 years, (2) BMI >40, and (3) surgical interventions performed by a member of the department of neurological surgery. Demographic, clinical, surgical, and post-operative follow-up were analyzed. Results: Patients were split into SMO (BMI 50+) and MO (BMI 40-50) groups. SMO received more intra-operative imaging radiation ( P = 0.0169), experienced longer hospital stays ( P < 0.0005) and experienced more post-operative complications than MO patients ( P = 0.008). SMO patients experienced more complications when discharged home than their MO counterparts ( P = 0.0002, RR = 12.2 [2.7-53.4]). Conclusion: Risk in SMO spine surgery can be reduced through weight loss, modified surgical approaches, and better discharge planning. Regardless of comorbidities, SMO patients discharged home face higher complication rates than MO patients and may benefit from early discussions about skilled nursing placement. Larger studies are needed to better assess surgical management and outcomes in this population.
- 23 September 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 31 (1) , 95-102
The Impact of Teriparatide on Clinical and Patient-Reported Outcomes in the Setting of Long-Segment Spine Fusion
BACKGROUND AND OBJECTIVES: Osteoporosis is a common comorbidity encountered in adult spinal deformity patients and is associated with increased perioperative and postoperative complications, including increased blood loss, pseudoarthrosis, and hardware failure. Teriparatide is a pro-osteogenic anabolic agent used to improve bone quality in patients with osteoporosis. This study evaluates the ability of teriparatide to mitigate complications in this cohort. METHODS: Patients diagnosed with adult spinal deformity who underwent long-segment thoracolumbar spine surgery at our institution between 2016 and 2020 were included in this study. Inclusion criteria include age >17 years, >5 levels of fusion, and use of pelvic instrumentation. A retrospective chart review was performed collecting demographic, radiographical, and treatment-related data with cohorts stratified by teriparatide therapy. RESULTS: There were 83 total patients that fit inclusion criteria. Twenty-two osteoporotic/osteopenic patients received teriparatide before surgery and 61 patients with normal bone density did not. Demographic differences were observed between the teriparatide group and nonteriparatide group regarding sex ( P = .014), body mass index ( P = .026), and preoperative dual energy X-ray absorptiometry scan T-score ( P < .001). Mechanical complications were not significantly different between cohorts at 1 year or 2 years. Change in Short Form Health Survey-36 pain scores at 1 year from time of index surgery was the only patient-reported outcome that was different between cohorts ( P = .018). CONCLUSION: The use of teriparatide before surgery for adult spinal deformity in patients with osteoporosis results in a similar complication profile to those undergoing spine surgery without osteoporosis and/or teriparatide use.
- 23 September 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 31 (1) , 95-102
The Impact of Teriparatide on Clinical and Patient-Reported Outcomes in the Setting of Long-Segment Spine Fusion
BACKGROUND AND OBJECTIVES: Osteoporosis is a common comorbidity encountered in adult spinal deformity patients and is associated with increased perioperative and postoperative complications, including increased blood loss, pseudoarthrosis, and hardware failure. Teriparatide is a pro-osteogenic anabolic agent used to improve bone quality in patients with osteoporosis. This study evaluates the ability of teriparatide to mitigate complications in this cohort. METHODS: Patients diagnosed with adult spinal deformity who underwent long-segment thoracolumbar spine surgery at our institution between 2016 and 2020 were included in this study. Inclusion criteria include age >17 years, >5 levels of fusion, and use of pelvic instrumentation. A retrospective chart review was performed collecting demographic, radiographical, and treatment-related data with cohorts stratified by teriparatide therapy. RESULTS: There were 83 total patients that fit inclusion criteria. Twenty-two osteoporotic/osteopenic patients received teriparatide before surgery and 61 patients with normal bone density did not. Demographic differences were observed between the teriparatide group and nonteriparatide group regarding sex ( P = .014), body mass index ( P = .026), and preoperative dual energy X-ray absorptiometry scan T-score ( P < .001). Mechanical complications were not significantly different between cohorts at 1 year or 2 years. Change in Short Form Health Survey-36 pain scores at 1 year from time of index surgery was the only patient-reported outcome that was different between cohorts ( P = .018). CONCLUSION: The use of teriparatide before surgery for adult spinal deformity in patients with osteoporosis results in a similar complication profile to those undergoing spine surgery without osteoporosis and/or teriparatide use.
- 10 April 2025
- Published by Elsevier in The Spine Journal
- Vol. 25 (11) , 2545-2552
Evaluation of fusion status in patients with minimum 1-year survival postoncologic spinal fusion
- 10 April 2025
- Published by Elsevier in The Spine Journal
- Vol. 25 (11) , 2545-2552
Evaluation of fusion status in patients with minimum 1-year survival postoncologic spinal fusion
- Open Access
- 3 February 2025
- Published by Elsevier in Journal of Orthopaedics
- Vol. 68, 58-61
Clinical and functional outcomes of reverse total shoulder arthroplasty for proximal humerus fracture versus rotator cuff arthropathy: A retrospective analysis
- 3 February 2025
- Published by Elsevier in Journal of Orthopaedics
- Vol. 68, 58-61
Open AccessClinical and functional outcomes of reverse total shoulder arthroplasty for proximal humerus fracture versus rotator cuff arthropathy: A retrospective analysis
- Open Access
- 6 January 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 249, 108731
3D printed titanium banana interbody cages versus titanium-coated PEEK bullet cages for TLIF
- 6 January 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 249, 108731
Open Access3D printed titanium banana interbody cages versus titanium-coated PEEK bullet cages for TLIF
- Open Access
- 11 June 2024
- Published by SAGE Publications in Global Spine Journal
- Vol. 15 (1) , 210-227
Machine Learning in Spine Oncology: A Narrative Review
Study Design: Narrative Review. Objective: Machine learning (ML) is one of the latest advancements in artificial intelligence used in medicine and surgery with the potential to significantly impact the way physicians diagnose, prognose, and treat spine tumors. In the realm of spine oncology, ML is utilized to analyze and interpret medical imaging and classify tumors with incredible accuracy. The authors present a narrative review that specifically addresses the use of machine learning in spine oncology. Methods: This study was conducted in accordance with the Preferred Reporting Items of Systematic Reviews and Meta-Analysis (PRISMA) methodology. A systematic review of the literature in the PubMed, EMBASE, Web of Science, Scopus, and Cochrane Library databases since inception was performed to present all clinical studies with the search terms ‘[[Machine Learning] OR [Artificial Intelligence]] AND [[Spine Oncology] OR [Spine Cancer]]’. Data included studies that were extracted and included algorithms, training and test size, outcomes reported. Studies were separated based on the type of tumor investigated using the machine learning algorithms into primary, metastatic, both, and intradural. A minimum of 2 independent reviewers conducted the study appraisal, data abstraction, and quality assessments of the studies. Results: Forty-five studies met inclusion criteria out of 480 references screened from the initial search results. Studies were grouped by metastatic, primary, and intradural tumors. The majority of ML studies relevant to spine oncology focused on utilizing a mixture of clinical and imaging features to risk stratify mortality and frailty. Overall, these studies showed that ML is a helpful tool in tumor detection, differentiation, segmentation, predicting survival, predicting readmission rates of patients with either primary, metastatic, or intradural spine tumors. Conclusion: Specialized neural networks and deep learning algorithms have shown to be highly effective at predicting malignant probability and aid in diagnosis. ML algorithms can predict the risk of tumor recurrence or progression based on imaging and clinical features. Additionally, ML can optimize treatment planning, such as predicting radiotherapy dose distribution to the tumor and surrounding normal tissue or in surgical resection planning. It has the potential to significantly enhance the accuracy and efficiency of health care delivery, leading to improved patient outcomes.
- 11 June 2024
- Published by SAGE Publications in Global Spine Journal
- Vol. 15 (1) , 210-227
Open AccessMachine Learning in Spine Oncology: A Narrative Review
Study Design: Narrative Review. Objective: Machine learning (ML) is one of the latest advancements in artificial intelligence used in medicine and surgery with the potential to significantly impact the way physicians diagnose, prognose, and treat spine tumors. In the realm of spine oncology, ML is utilized to analyze and interpret medical imaging and classify tumors with incredible accuracy. The authors present a narrative review that specifically addresses the use of machine learning in spine oncology. Methods: This study was conducted in accordance with the Preferred Reporting Items of Systematic Reviews and Meta-Analysis (PRISMA) methodology. A systematic review of the literature in the PubMed, EMBASE, Web of Science, Scopus, and Cochrane Library databases since inception was performed to present all clinical studies with the search terms ‘[[Machine Learning] OR [Artificial Intelligence]] AND [[Spine Oncology] OR [Spine Cancer]]’. Data included studies that were extracted and included algorithms, training and test size, outcomes reported. Studies were separated based on the type of tumor investigated using the machine learning algorithms into primary, metastatic, both, and intradural. A minimum of 2 independent reviewers conducted the study appraisal, data abstraction, and quality assessments of the studies. Results: Forty-five studies met inclusion criteria out of 480 references screened from the initial search results. Studies were grouped by metastatic, primary, and intradural tumors. The majority of ML studies relevant to spine oncology focused on utilizing a mixture of clinical and imaging features to risk stratify mortality and frailty. Overall, these studies showed that ML is a helpful tool in tumor detection, differentiation, segmentation, predicting survival, predicting readmission rates of patients with either primary, metastatic, or intradural spine tumors. Conclusion: Specialized neural networks and deep learning algorithms have shown to be highly effective at predicting malignant probability and aid in diagnosis. ML algorithms can predict the risk of tumor recurrence or progression based on imaging and clinical features. Additionally, ML can optimize treatment planning, such as predicting radiotherapy dose distribution to the tumor and surrounding normal tissue or in surgical resection planning. It has the potential to significantly enhance the accuracy and efficiency of health care delivery, leading to improved patient outcomes.
- Open Access
- 18 May 2024
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 34 (3) , 730-737
The role of smoking status on survivorship and clinical outcomes following total shoulder arthroplasty
- 18 May 2024
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 34 (3) , 730-737
Open AccessThe role of smoking status on survivorship and clinical outcomes following total shoulder arthroplasty
- Open Access
- 5 May 2024
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 34 (3) , 672-678
Staged bilateral total shoulder arthroplasty: a single institutional experience with mid-term follow-up
- 5 May 2024
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 34 (3) , 672-678
Open AccessStaged bilateral total shoulder arthroplasty: a single institutional experience with mid-term follow-up
- Open Access
- 12 April 2024
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 34 (3) , 577-584
Clinical evaluation of patients over the age of 75 receiving either anatomic or reverse total shoulder arthroplasty: a single-institution retrospective analysis
- 12 April 2024
- Published by Elsevier in Seminars in Arthroplasty: JSES
- Vol. 34 (3) , 577-584
Open AccessClinical evaluation of patients over the age of 75 receiving either anatomic or reverse total shoulder arthroplasty: a single-institution retrospective analysis
- 28 February 2024
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (9) , 1980-1989
The role of body mass index in survivorship and clinical outcomes in total shoulder arthroplasty
- 28 February 2024
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (9) , 1980-1989
The role of body mass index in survivorship and clinical outcomes in total shoulder arthroplasty